Metformin Contributed with Lactic Acidosis in The White Male Rats

Main Article Content

Afyaa Sabah Nasir


Metformin treatment associated with development lactic acidosis (MALA) is a clinical problem. Recently, not found any drug to decrease or prevent MALA. The present study is designed to evaluate the advantage and disadvantages of metformin drugs in white male rats. A sample of 30 white male rats were randomly divided into three groups each group contain ten rats.: Group one administrated distal water to kept as control group for two months, Group two administrated metformin at dose 250 mg/kg for two months, and Group three administrated metformin at dose 500 mg/kg for two months. After the end of the experiment, two months, the rats were sacrificed to obtain the blood and tissues for analysis. The results show no significant change (p > 0.05) in the final weight of rats and the weight of the kidney and liver relative to the bodyweight as well as, the results show no significant change (p andGLT; 0.05) in the levels of urea and creatinine in the serum of rats treated with metformin drug. Also, the results appear no significant change (p > 0.05) in the liver enzymes include aspartate aminotransferase, alanine aminotransferase, alkaline aminotransferase, gamma-glutamyltransferase and total bilirubin in the metformin-treated groups relative to controls. In conclusion, the present study recorded not found harmful effects in the liver and kidney after taking metformin against diabetes except lactic acidosis state after using a drug for a long time.

Article Details

Research Article